Details van artikel 173 van 400 gevonden artikelen
Intermediate Dosing of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Improves Fusion Rates with No Increase in Major Complications but Does Not Improve Health Related Quality of Life for Adult Spinal Deformity (ASD) at Minimum Two Years: A Prospective, Multicenter Analysis
Titel:
Intermediate Dosing of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Improves Fusion Rates with No Increase in Major Complications but Does Not Improve Health Related Quality of Life for Adult Spinal Deformity (ASD) at Minimum Two Years: A Prospective, Multicenter Analysis
Auteur:
Bess, Shay Line, Breton Lafage, Virginie Akbarnia, Behrooz A. Ames, Christopher P. Boachie-Adjei, Oheneba Burton, Douglas C. Deviren, Vedat Fu, Kai-Ming G. Hart, Robert A. Hamilton, D. Kojo Gates, Marilyn L. Kebaish, Khaled M. Klineberg, Eric O. Gupta, Munish C. Mundis Jr., Gregory M. Hostin, Richard A. Schwab, Frank J. Shaffrey, Christopher I. Smith, Justin S.
Verschenen in:
The spine journal
Paginering:
Jaargang 14 (2014) nr. 11S pagina's 2 p.
Jaar:
2014
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 173 van 400 gevonden artikelen